Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa.
about
Can Novel Treatment of Age-Related Macular Degeneration Be Developed by Better Understanding of Sorsby's Fundus DystrophyClinical features of a novel TIMP-3 mutation causing Sorsby's fundus dystrophy: implications for disease mechanismTIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix.Clinical and biochemical effects of the E139K missense mutation in the TIMP3 gene, associated with Sorsby fundus dystrophy.Matrix metalloproteinase biology applied to vitreoretinal disorders.Identification of novel retinal target genes of thyroid hormone in the human WERI cells by expression microarray analysis.Rare and common variants in extracellular matrix gene Fibrillin 2 (FBN2) are associated with macular degeneration.Human retinal pigment epithelial lysis of extracellular matrix: functional urokinase plasminogen activator receptor, collagenase, and elastaseThe effect of TIMP-1 on the cone mosaic in the retina of the rat model of retinitis pigmentosa.Histopathological comparison of eyes from patients with autosomal recessive retinitis pigmentosa caused by novel EYS mutations.Retinal histopathology in eyes from patients with autosomal dominant retinitis pigmentosa caused by rhodopsin mutations.Tissue inhibitor of metalloproteinase-3 differentially binds to components of Bruch's membrane.Matrix bound SFD mutant TIMP-3 is more stable than wild type TIMP-3Characterization of the gelatinase system of the laminar human optic nerve, and surrounding annulus of Bruch's membrane, choroid, and sclera.Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASILInfluence of TIMP3/SYN3 polymorphisms on the phenotypic presentation of age-related macular degeneration.S156C mutation in tissue inhibitor of metalloproteinases-3 induces increased angiogenesisStructural and biochemical analyses of choroidal thickness in human donor eyes.Gene transfer for ocular neovascularization and macular edema.Expression of Sorsby's fundus dystrophy mutations in human retinal pigment epithelial cells reduces matrix metalloproteinase inhibition and may promote angiogenesis.Adenovirus mediated gene delivery of tissue inhibitor of metalloproteinases-3 induces death in retinal pigment epithelial cells.Myocilin Regulates Metalloprotease 2 Activity Through Interaction With TIMP3.Drusen in patient-derived hiPSC-RPE models of macular dystrophies.Timp-3 deficiency impairs cognitive function in mice.Sorsby fundus dystrophy presenting with choroidal neovascularisation showing good response to steroid treatment.Sorsby's fundus dystrophy mutant tissue inhibitors of metalloproteinase-3 induce apoptosis of retinal pigment epithelial and MCF-7 cells.Sorsby's fundus dystrophy mutations impair turnover of TIMP-3 by retinal pigment epithelial cells.Tissue inhibitor of metalloproteinases 1 enhances rod survival in the rd1 mouse retina.
P2860
Q26799529-3F24ACBD-361F-4D5D-A3B0-D3DBB2F9EB7AQ28365808-F630D8FA-C044-4E4A-9A90-73A17231E2B4Q30886270-B1804A4F-0173-4E0E-BEAB-00C6F0B1B4BFQ33470273-027A24E2-0D2F-4F54-9EC1-6DE65AC8D7F7Q33933063-2AB36D12-05C1-4EEF-83EF-73AA518223C3Q34100952-C74B5E21-4C6D-4C22-8E22-21B87AB886E9Q34307274-A080A17E-F104-463B-80B7-8AD14F81219EQ34330943-2EFE8429-0970-449F-A27F-8A0FE2C42598Q34956156-25446B62-5E03-4734-BDA8-159496AF2263Q35505179-51455B87-82B3-4BAC-81CD-DA78D4B29F9FQ35706943-2B3F485F-90BF-40FF-9B9C-BEC37E9DFF56Q35762549-55C46C2B-8B2B-4E67-ADF9-41DFCC8FB479Q35953731-A2D85299-ACB2-40FA-BF61-49BE54103ADFQ36098916-D82AFD8A-458C-4E73-A4ED-9260BF3E21B0Q36904906-F9E525CE-61EC-4F2C-8ABB-FD704937C27BQ37186026-39F7B730-C3A4-4A9E-8BB0-BD25CEECB54FQ37338976-873F324F-10FF-4B8E-BE51-0BDF09965EF2Q37623611-BB7F72FD-B786-4725-BF15-44BCF5429D55Q37954532-C4F595E8-F77F-44C7-9392-8A4080B9E42DQ40753407-6F576822-F844-41F9-9096-D3DA4DE0C9DEQ40756228-8CECE73B-38BB-488D-BE05-D3DE332F1033Q42379452-7FA1512F-10D2-498C-88F1-D3A2863BD5A3Q42514513-AEB1CA2B-D583-4517-8586-392916962B3DQ42645135-D7B89265-AAD8-4F9B-A5D4-5BE09941DDF6Q43008034-72156878-AC90-492A-BA5F-2D46BFE0A1E4Q44174063-3E9FF12A-E8D0-4DF6-8212-0917A7D55FB2Q46751935-D9452E86-D06E-44C1-ABEE-D75F4481713FQ55333805-4F2BFC54-3143-4E3F-9C9D-E1B6B5E118B0
P2860
Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Accumulation of tissue inhibit ...... rophy or retinitis pigmentosa.
@ast
Accumulation of tissue inhibit ...... rophy or retinitis pigmentosa.
@en
type
label
Accumulation of tissue inhibit ...... rophy or retinitis pigmentosa.
@ast
Accumulation of tissue inhibit ...... rophy or retinitis pigmentosa.
@en
prefLabel
Accumulation of tissue inhibit ...... rophy or retinitis pigmentosa.
@ast
Accumulation of tissue inhibit ...... rophy or retinitis pigmentosa.
@en
P2093
P2860
P356
P1476
Accumulation of tissue inhibit ...... rophy or retinitis pigmentosa.
@en
P2093
P2860
P304
P356
10.1136/BJO.82.11.1329
P407
P577
1998-11-01T00:00:00Z